Anti-IgE [EPC] - N0000175794

Pharmacologic Code	N0000175794
Pharmacologic Name	Anti-IgE
Pharmacologic Uses	anti-IgE
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Anti-IgE [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-040	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-214	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-215	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-227	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	72606-052	Omalizumab-igec	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion, Inc.	ACTIVE
	72606-053	Omalizumab-igec	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion, Inc.	ACTIVE
	72606-061	Omalizumab-igec	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion, Inc.	ACTIVE